Graduates of UTHSC accelerated nursing program enter front lines of pandemic
UTHSC Accelerated Program grads start career during a pandemic By Camille Connor | January 25, 2021 at 6:20 PM CST - Updated January 26 at 9:58 AM
MEMPHIS, Tenn. (WMC) - An accelerated nursing program that started in 2019 is now producing nurses who have started their careers in the middle of a pandemic.
WMC Action News 5 spoke with the director of the University of Tennessee Health Science Center program.
Earning a BSN in a year, that’s what UTHSC’s current round of applicants will do once they complete the accelerated nursing program.
It’s second degree. So, they already have a bachelor’s degree in another field,” said Dr. Randall Johnson, Program Director, UTSHC Accelerated Nursing Program.
Updated: 1:30 PM CST January 25, 2021
MEMPHIS, Tenn. Researchers at the University of Tennessee Health Science Center have played a supporting role in the development of COVID-19 vaccines.
To examine the efficacy of the Pfizer-BioNTech vaccine during development, the company needed a way to test the inhibitory effects of the antibodies generated after vaccination on virus infection. However, to work with SARS-CoV-2 requires a Biosafety Level-3 laboratory, which most companies do not have. To reduce the risk to workers testing the vaccine, Pfizer-BioNTech and other companies developing vaccines against COVID-19 have utilized a surrogate system, one of which was developed in the laboratory of Michael Whitt, PhD, associate dean of the Office of Medical Education in the UTHSC College of Medicine, chair of the Department of Medical Education, and a professor and former chair of the Department of Microbiology, Immunology, and Biochemistry at the University of Tennessee
The roll out of COVID-19 vaccines has been slower than expected, which public officials say is the result of a limited national supply chain. Chief Operating Officer for the City of Memphis Doug McGowen says Shelby County is ready to administer as many doses as the state of Tennessee can send.
McGowen join this week’s WKNO-TV Behind the Headlines with host Eric Barnes and The Daily Memphian’s Bill Dries, along with Dr. Jon McCullers, the dean of clinical affairs at the University of Tennessee Health Science Center. They discuss the Shelby County Joint Task Force s ongoing work to get vaccines into arms and what future distribution might look like.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021
Amicus Therapeutics, Inc.January 21, 2021 GMT
CRANBURY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that three oral presentations and ten posters highlighting its development programs for Lysosomal Disorders will be included at the 17th Annual WORLD
Symposium ™ 2021, to be held virtually February 8-12, 2021.
ADVERTISEMENT
Oral Platform Presentations:
Direct intercellular cross-correction of α-galactosidase-A deficiency in Fabry disease podocytes through tunneling nanotubes in a mixed cell culture model – Behzad Najafian, MD, Department of Pathology, University of Washington, Seattle, WA, USA (Monday, F